search
Back to results

Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture

Primary Purpose

Capsular Contracture of Breast, Grade III

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Aspen(TM) Ultrasound System
Sponsored by
Nina Naidu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Capsular Contracture of Breast, Grade III focused on measuring breast implant capsular contracture

Eligibility Criteria

22 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

Stage I:

  • Age 22 years or greater,
  • Cosmetic breast augmentation,
  • Baker Grade III capsular contracture, subglandular implant position, saline implants.

Stage II:

  • Age 22 years or greater,
  • Cosmetic breast augmentation,
  • Baker Grade III capsular contracture, subglandular or submuscular implant position, saline or silicone gel implants.

Exclusion Criteria:

  • History of breast cancer,
  • prior radiation therapy to chest wall,
  • ruptured breast implant,
  • calcification of capsules seen on any imaging study,
  • implants > 15 years old,
  • prior treatment for capsular contracture in past 12 months (open capsulectomy, open capsulotomy, implant exchange, implant plane change, placement of acellular dermal matrix, explantation, closed capsulotomy, or oral medication),
  • metal implants,
  • pacemakers,
  • defibrillators,
  • history of epilepsy,
  • history of bleeding, and undiagnosed pain syndromes,
  • pregnancy,
  • currently lactating,
  • acute and sub-acute thrombosis and thrombophlebitis,
  • potentially malignant tumors,
  • benign tumors,
  • malignancy,
  • third-degree musculotendinous lesions,
  • multiple sclerosis,
  • osteomyelitis,
  • cardiac arrhythmias,
  • acute sepsis of tissue or bone,
  • arteriosclerosis,
  • hemophilia, and
  • sensory nerve damage.

Sites / Locations

  • Nina S. Naidu, MD PC

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment Patients

Arm Description

In stage I, 10 women aged 22 years or older who have received silicone or saline breast implants for subglandular or submuscular breast augmentation, and who subsequently developed Baker Grade III capsular contracture, will be invited to participate. In Stage II, the study group will be expanded to include an additional 50 patients who have received saline or silicone gel implants, placed in either the subglandular or submuscular position, with Grade III capsular contracture of the breast. The intervention will be treatment with the Aspen(TM) Ultrasound System.

Outcomes

Primary Outcome Measures

Safety (defined by no adverse events, including implant rupture, skin burns) of the Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture Baker Grade III
The determination of safety as defined by no adverse events, including implant rupture, skin burns,
Efficacy (reduction of at least one Baker Grade following treatment) of the Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture Baker Grade III
The documentation of efficacy as demonstrated by the reduction of at least one Baker Grade following treatment.

Secondary Outcome Measures

Full Information

First Posted
July 19, 2016
Last Updated
June 10, 2021
Sponsor
Nina Naidu
search

1. Study Identification

Unique Protocol Identification Number
NCT02840084
Brief Title
Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture
Official Title
A Study on the Safety and Effectiveness of the Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture Baker Grade III
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Terminated
Why Stopped
adverse event
Study Start Date
September 15, 2019 (Actual)
Primary Completion Date
June 10, 2021 (Actual)
Study Completion Date
June 10, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Nina Naidu

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Purpose: The purpose of this investigation is to test the safety and effectiveness of the Aspen System™ and Aspen Rehabilitation Technique. The device is intended for the therapeutic treatment of capsular contracture of the breast in conjunction with the Aspen Rehabilitation Technique. The hypothesis of the proposed study is that external ultrasound with the Aspen System™ device in conjunction with the Aspen Rehabilitation Technique is safe and effective in the reduction by at least one level of Baker Grade III capsular contracture in cosmetic breast augmentation patients, maintained at one year from the final treatment. Potential benefits of the study to subjects include improvement in the grade of capsular contracture of the breast without surgical treatment. The investigation is planned to last 12 months.
Detailed Description
Protocol: Objectives: Two stages are proposed for this study. In Stage I, the objective is to demonstrate the safety of the Aspen System™ and Aspen Rehabilitation Technique in the treatment of Baker Grade III capsular contracture of the breast following subglandular or submuscular placement of saline or silicone implants for cosmetic breast augmentation. The endpoint will be the determination of safety as defined by no adverse events, including implant rupture. Following review of interim data and approval by the FDA, Stage II will commence. In Stage II, the objective will be to demonstrate safety and efficacy of the Aspen System™ and Aspen Rehabilitation Technique in the treatment of Baker Grade III capsular contracture of the breast following subglandular or submuscular placement of saline or silicone implants for cosmetic breast augmentation. The endpoint will be the documentation of efficacy as demonstrated by the reduction of at least one Baker Grade following treatment with the Aspen™ System and Aspen Rehabilitation Technique. Description: This is a prospective, non-randomized trial. Conduct: The trial will be conducted as follows: Study Subjects: Patients will be recruited from the investigator's private practice and the local community. In stage I, 10 women aged 22 years or older who have received saline or silicone breast implants for subglandular or submuscular breast augmentation, and who subsequently developed Baker Grade III capsular contracture, will be invited to participate. Upon completion of the first stage of this study, the data will be submitted to the FDA for review. The second stage of the study will not commence until approval has been obtained by the FDA. At this time, for the second stage of the study, the study group will be expanded to include an additional 50 patients who have received saline or silicone gel implants, placed in either the subglandular or submuscular position, with Grade III capsular contracture of the breast.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Capsular Contracture of Breast, Grade III
Keywords
breast implant capsular contracture

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment Patients
Arm Type
Experimental
Arm Description
In stage I, 10 women aged 22 years or older who have received silicone or saline breast implants for subglandular or submuscular breast augmentation, and who subsequently developed Baker Grade III capsular contracture, will be invited to participate. In Stage II, the study group will be expanded to include an additional 50 patients who have received saline or silicone gel implants, placed in either the subglandular or submuscular position, with Grade III capsular contracture of the breast. The intervention will be treatment with the Aspen(TM) Ultrasound System.
Intervention Type
Device
Intervention Name(s)
Aspen(TM) Ultrasound System
Intervention Description
Two transducers per breast are applied. There will be 10 30 minute sessions, with 2 sessions per week for five weeks. The transducers will be placed on the medial and lateral positions of the affected breast, and then rotated to the superior and inferior aspects, and finally directly over the nipple-areolar complex. Following treatment, the affected breast will be massaged and bandaged per the Aspen Rehabilitation protocol, and the patient will be provided with home exercises as part of the Aspen Rehabilitation Technique. The treated breast(s) will be examined both prior to and immediately following each treatment session. To evaluate safety, any adverse events such as swelling, redness, or pain will be assessed. To determine efficacy, any change in the Baker Grade level will be assessed by physical examination. The breasts will be photographed prior to treatment at each visit to assist in evaluation of any visible change in the breasts.
Primary Outcome Measure Information:
Title
Safety (defined by no adverse events, including implant rupture, skin burns) of the Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture Baker Grade III
Description
The determination of safety as defined by no adverse events, including implant rupture, skin burns,
Time Frame
12 months
Title
Efficacy (reduction of at least one Baker Grade following treatment) of the Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture Baker Grade III
Description
The documentation of efficacy as demonstrated by the reduction of at least one Baker Grade following treatment.
Time Frame
12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
22 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Stage I: Age 22 years or greater, Cosmetic breast augmentation, Baker Grade III capsular contracture, subglandular implant position, saline implants. Stage II: Age 22 years or greater, Cosmetic breast augmentation, Baker Grade III capsular contracture, subglandular or submuscular implant position, saline or silicone gel implants. Exclusion Criteria: History of breast cancer, prior radiation therapy to chest wall, ruptured breast implant, calcification of capsules seen on any imaging study, implants > 15 years old, prior treatment for capsular contracture in past 12 months (open capsulectomy, open capsulotomy, implant exchange, implant plane change, placement of acellular dermal matrix, explantation, closed capsulotomy, or oral medication), metal implants, pacemakers, defibrillators, history of epilepsy, history of bleeding, and undiagnosed pain syndromes, pregnancy, currently lactating, acute and sub-acute thrombosis and thrombophlebitis, potentially malignant tumors, benign tumors, malignancy, third-degree musculotendinous lesions, multiple sclerosis, osteomyelitis, cardiac arrhythmias, acute sepsis of tissue or bone, arteriosclerosis, hemophilia, and sensory nerve damage.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nina Naidu, MD
Organizational Affiliation
surgeon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nina S. Naidu, MD PC
City
New York
State/Province
New York
ZIP/Postal Code
10028
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Non-identified data may be made available to the FDA if requested.

Learn more about this trial

Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture

We'll reach out to this number within 24 hrs